Literature DB >> 10188781

Molecular probes for muscarinic receptors: functionalized congeners of selective muscarinic antagonists.

K A Jacobson1, B Fischer, A M van Rhee.   

Abstract

The muscarinic agonist oxotremorine and the tricyclic muscarinic antagonists pirenzepine and telenzepine have been derivatized using a functionalized congener approach for the purpose of synthesizing high affinity ligand probes that are suitable for conjugation with prosthetic groups, for receptor cross-linking, fluorescent and radioactive detection, etc. A novel fluorescent conjugate of TAC (telenzepine amine congener), an n-decylamino derivative of the m1-selective antagonist, with the fluorescent trisulfonated pyrene dye Cascade Blue may be useful for assaying the receptor as an alternative to radiotracers. In a rat m3 receptor mutant containing a single amino acid substitution in the sixth transmembrane domain (Asn507 to Ala) the parent telenzepine lost 636-fold in affinity, while TAC lost only 27-fold. Thus, the decylamino group of TAC stabilizes the bound state and thus enhances potency by acting as a distal anchor in the receptor binding site. We have built a computer-assisted molecular model of the transmembrane regions of muscarinic receptors based on homology with the G-protein coupled receptor rhodopsin, for which a low resolution structure is known. We have coordinated the antagonist pharmacophore (tricyclic and piperazine moieties) with residues of the third and seventh helices of the rat m3 receptor. Although the decylamino chain of TAC is likely to be highly flexible and may adopt many conformations, we located one possible site for a salt bridge formation with the positively charged -NH3+ group, i.e. Asp113 in helix II.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 10188781      PMCID: PMC3561779          DOI: 10.1016/0024-3205(95)00016-y

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  23 in total

1.  Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.

Authors:  K A Jacobson; G L Stiles; X D Ji
Journal:  Mol Pharmacol       Date:  1992-07       Impact factor: 4.436

2.  Characterization of benzodiazepine receptors with a fluorescence-quenching ligand.

Authors:  R H Havunjian; B R De Costa; K C Rice; P Skolnick
Journal:  J Biol Chem       Date:  1990-12-25       Impact factor: 5.157

Review 3.  Molecular basis of muscarinic acetylcholine receptor function.

Authors:  J Wess
Journal:  Trends Pharmacol Sci       Date:  1993-08       Impact factor: 14.819

4.  Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.

Authors:  B J Bradbury; J Baumgold; K A Jacobson
Journal:  J Med Chem       Date:  1990-02       Impact factor: 7.446

5.  Functional role in ligand binding and receptor activation of an asparagine residue present in the sixth transmembrane domain of all muscarinic acetylcholine receptors.

Authors:  K Blüml; E Mutschler; J Wess
Journal:  J Biol Chem       Date:  1994-07-22       Impact factor: 5.157

6.  Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy.

Authors:  R Henderson; J M Baldwin; T A Ceska; F Zemlin; E Beckmann; K H Downing
Journal:  J Mol Biol       Date:  1990-06-20       Impact factor: 5.469

7.  Projection structure of rhodopsin.

Authors:  G F Schertler; C Villa; R Henderson
Journal:  Nature       Date:  1993-04-22       Impact factor: 49.962

8.  High affinity acylating antagonists for muscarinic receptors.

Authors:  J Baumgold; Y Karton; N Malka; K A Jacobson
Journal:  Life Sci       Date:  1992       Impact factor: 5.037

9.  Identification of potent, selective P2Y-purinoceptor agonists: structure-activity relationships for 2-thioether derivatives of adenosine 5'-triphosphate.

Authors:  B Fischer; J L Boyer; C H Hoyle; A U Ziganshin; A L Brizzolara; G E Knight; J Zimmet; G Burnstock; T K Harden; K A Jacobson
Journal:  J Med Chem       Date:  1993-11-26       Impact factor: 7.446

10.  Molecular probes for muscarinic receptors: derivatives of the M1-antagonist telenzepine.

Authors:  Y Karton; J Baumgold; J S Handen; K A Jacobson
Journal:  Bioconjug Chem       Date:  1992 May-Jun       Impact factor: 4.774

View more
  3 in total

1.  Modelling the P2Y purinoceptor using rhodopsin as template.

Authors:  A M Van Rhee; B Fischer; P J Van Galen; K A Jacobson
Journal:  Drug Des Discov       Date:  1995-11

2.  Differently fluorescence-labelled dibenzodiazepinone-type muscarinic acetylcholine receptor ligands with high M2R affinity.

Authors:  Corinna G Gruber; Andrea Pegoli; Christoph Müller; Lukas Grätz; Xueke She; Max Keller
Journal:  RSC Med Chem       Date:  2020-06-08

Review 3.  Modular Approaches to Synthesize Activity- and Affinity-Based Chemical Probes.

Authors:  Antonie J van der Zouwen; Martin D Witte
Journal:  Front Chem       Date:  2021-04-15       Impact factor: 5.221

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.